期刊
FRONTIERS IN CARDIOVASCULAR MEDICINE
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcvm.2022.1040251
关键词
left ventricular assist device (LVAD); heart failure (HF); right ventricle (RV); right ventricular failure (RVF); right ventricular assist device (RVAD); hemocompatibility adverse events (HRAE)
资金
- Spanish Society of Cardiology (Magda Heras grant) [SEC/MHE-MOV-INT 21/001]
- TRANSFORM HF
This review discusses the occurrence of RVF in LVAD patients and provides multiple tools for predicting the risk of RVF, aiding in the selection of suitable LVAD candidates. It also presents a multidisciplinary approach to early RVF management and the indications and management of right ventricular assist devices.
Left ventricular assist devices (LVADs) are increasingly common across the heart failure population. Right ventricular failure (RVF) is a feared complication that can occur in the early post-operative phase or during the outpatient follow-up. Multiple tools are available to the clinician to carefully estimate the individual risk of developing RVF after LVAD implantation. This review will provide a comprehensive overview of available tools for RVF prognostication, including patient-specific and right ventricle (RV)-specific echocardiographic and hemodynamic parameters, to provide guidance in patient selection during LVAD candidacy. We also offer a multidisciplinary approach to the management of early RVF, including indications and management of right ventricular assist devices in this setting to provide tools that help managing the failing RV.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据